Últimas noticias sobre Cassava Sciences (NASDAQ:SAVA) Bolsa

CASSAVA SCIENCES INC

Cassava Sciences

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Cassava Sciences Inc

Cassava Sciences Inc Warrants (15/11/2024)

SAVANNAH GOLDFIELDS LTD by SAVANNAH GOLDFIELDS LTD

SAVANNAH ENERGY PLC by Savannah Energy Plc

Savannah Energy PLC

SAVANNAH RESOURCES PLC by SAVANNAH RESOURCES PLC

Savannah Resources PLC

Savara Inc

Savaria Corp

As of June 16, 2025, two stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Velocity Financial Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEL#NYSE">VEL</a>)</h3>
<ul class="wp-block-list">
<li>On May 1, Velocity Financial posted better-than-expected quarterly earnings. &#8220;We began 2025 with tremendous momentum, delivering a new record for quarterly production volume and solid earnings,&#8221; said Chris Farrar, President and CEO. &#8220;Velocity&#8217;s first quarter 2025 results were driven by higher portfolio net interest income and noninterest income from our growing production volume.&#8221; The company's stock jumped around 13% over the past five days and has a 52-week high of $20.98.</li>
<li>RSI Value: 79.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>VEL Price Action: Shares of Velocity Financial gained 0.1% to close at $19.22 on Friday.</li>
<li>Edge Stock Ratings: 46.49 Momentum score.</li>
</ul>
<h3 class="wp-block-heading">AlTi Global, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>)</h3>
<ul class="wp-block-list">
<li>On May 12, AlTi Global posted mixed results for the first quarter. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/ALTI">has a 52-week high</a> of $5.45.</li>
<li>RSI Value: 71.3</li>
<li>ALTI Price Action: Shares of AlTi Global fell 0.3% to close at $3.92 on Friday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>.
Read This Next:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45924005/top-2-energy-stocks-that-may-fall-off-a-cliff-in-june"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45924005/top-2-energy-stocks-that-may-fall-off-a-cliff-in-june">Top 2 Energy Stocks That May Fall Off A Cliff in June</a> </li>
</ul>
Photo via Shutterstock

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ALTI

Top 2 Financial Stocks That May Plunge in Q2

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>TD Cowen analyst Robert Moskow upgraded the rating for Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) from Hold to Buy and raised the price target from $37 to $55. Celsius Holdings shares closed at $41.16 on Friday. <a href="https://www.benzinga.com/quote/CELH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Philip Ng upgraded Smurfit Westrock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) from Hold to Buy and boosted the price target from $44 to $55. Smurfit WestRock shares closed at $41.98 on Friday. <a href="https://www.benzinga.com/quote/SW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Orest Wowkodaw upgraded the rating for Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) from Sector Perform to Sector Outperform and raised the price target from $43 to $48. Freeport-McMoRan shares closed at $40.94 on Friday. <a href="https://www.benzinga.com/quote/FCX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison upgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Equal-Weight to Overweight and raised the price target from $45 to $66. Celanese shares closed at $54.63 on Friday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Alec Brondolo upgraded the rating for Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) from Equal-Weight to Overweight and increased the price target from $173 to $21. Wix.com shares closed at $149.10 on Friday. <a href="https://www.benzinga.com/quote/WIX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/CE/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16091202/image-241-1024x574.png" alt="" class="wp-image-950753" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16091202/image-241-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16091202/image-241-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16091202/image-241-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16091202/image-241.png 1135w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45946608/top-3-materials-stocks-that-could-blast-off-this-month-3">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

Analyst Color

Upgrades

CELH

This Celanese Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Maxim Group analyst Allen Klee downgrades Ohmyhome (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMH#NASDAQ">OMH</a>) from Buy to Hold.

Downgrades

Analyst Ratings

Maxim Group Downgrades Ohmyhome to Hold

<a href="https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time" title="https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time">https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time</a>

'WhatsApp to Show Ads, Offer Paid Subscriptions for First Time' - Bloomberg News

Future flight-testing targets 30% improved fuel efficiency for regional turboprops
PARIS, June 16, 2025 /PRNewswire/ -- Pratt &amp; Whitney Canada announces a new milestone in the RTX Hybrid-Electric Flight Demonstrator project, by testing the integrated propulsion system and batteries to full power. While ground testing of the hybrid-electric propulsion system continues in Longueuil, Quebec, Pratt &amp; Whitney Canada has selected AeroTEC to support future flight testing of the De Havilland Canada Dash 8-100 experimental aircraft. Pratt &amp; Whitney is an RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) business.
The new end-to-end test marks the first battery-powered operation of the propulsion system, which combines a highly efficient Pratt &amp; Whitney Canada thermal engine with a 1 megawatt (MW) electric motor developed by RTX business, Collins Aerospace. The 200 kilowatt-hour (kWh) batteries, supplied by H55 S.A., have also been successfully charged and discharged using the high-voltage <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4449457-1&amp;h=1885069606&amp;u=https%3A%2F%2Fwww.prattwhitney.com%2Fen%2Fnewsroom%2Fnews%2F2024%2F01%2F22%2Frtxs-pratt-whitney-canada-unveils-mobile-charging-unit-for-hybrid-electric-flight-demonstrator&amp;a=Mobile+Charging+Unit">Mobile Charging Unit</a>&nbsp;co-developed by Pratt &amp; Whitney Canada, the National Research Council of Canada and the Innovative Vehicle Institute.&nbsp;H55 is supported by RTX Ventures, the venture capital arm of RTX.

CORRECTION: Pratt & Whitney Canada Achieves Full-Power Test Of Hybrid-Electric Propulsion System For Dash 8-100 Experimental Aircraft

Loop Capital analyst Anthony Chukumba maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Buy and raises the price target from $480 to $510.

Price Target

ULTA

Loop Capital Maintains Buy on Ulta Beauty, Raises Price Target to $510

Bon Natural Life Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) ("Bon" or the "Company"), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading Co., Ltd., a prominent Asia-Pacific fragrance chemical distributor ("Merrill-Youli"). The term of the agreement is 36 months with a total contract value of up to US$18 million. Pursuant to the agreement, Merrill-Youli will market, sell and distribute Bon's Ambroxide and related natural fragrance compounds in the Asia-Pacific region. Merrill-Youli will primarily target the industrial fabric fragrance sector.
Ambroxide is a synthetic molecule used in perfumery to create ambergris notes and act as a fixative. It's a cruelty-free alternative to the natural ambergris, which is derived from sperm whales. Ambroxide is known for its velvety, woody, and ambery scent with animalic, creamy, and mineral facets and has long been a staple in perfumery. In recent years, Ambroxide has rapidly expanded into the much larger fabric fragrance market, thanks to its strong performance, lower production costs, and reliable supply. Manufacturing has scaled up dramatically—from thousands to tens of thousands of tons—and the market is expected to grow by over 25% each year for the next five years.
Bon believes this partnership will help capitalize a leading position in Ambroxide products leveraging Merrill-Youli's established market presence in fragrance chemicals. The collaboration aims to accelerate adoption of Bon's Ambroxide line across Asia-Pacific fragrance markets, particularly in fabric applications. Bon plans to use its advanced Ambroxide technology to boost sales growth, increase profits in its fragrance chemicals business, and deliver greater value to its shareholders.
Additionally, Bon has made a breakthrough in developing a biosynthetic alternative to Sclareol—the key natural ingredient used to produce Ambroxide. After starting the project in 2023, the Company has now confirmed that the technology is on track for commercial launch. Production capacity is now expected to scale rapidly, from thousands to tens of thousands of tons per year, and the new process also offers cost savings, enhancing overall efficiency and profitability.
Bon believes this will further strengthen its competitive position and will open the door to expanding beyond perfumery into the much larger textile fragrance market—a rapidly growing industry with significant scale and untapped potential.

Bon Natural Life Secures $18M, 36-Month Sales Distribution Agreement with Tianjin Merrill-Youli

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">241.00</td>
<td align="right">1.83</td>
<td align="right">0.76</td>
<td>13.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">103.35</td>
<td align="right">0.77</td>
<td align="right">0.75</td>
<td>6.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.33</td>
<td align="right">0.37</td>
<td align="right">0.74</td>
<td>141.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">143.32</td>
<td align="right">0.67</td>
<td align="right">0.46</td>
<td>3.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">136.54</td>
<td align="right">0.41</td>
<td align="right">0.30</td>
<td>2.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.20</td>
<td align="right">0.24</td>
<td align="right">0.29</td>
<td>820</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.65</td>
<td align="right">0.23</td>
<td align="right">0.28</td>
<td>9.7K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">87.5</td>
<td align="right">-0.6</td>
<td align="right">-0.69</td>
<td>739.5K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Movers

ETFs

Leading And Lagging Sectors For June 16, 2025

Keybanc analyst Todd Thomas maintains Smartstop Self Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMA#NYSE">SMA</a>) with a Overweight and raises the price target from $38 to $40.

Keybanc Maintains Overweight on Smartstop Self Storage, Raises Price Target to $40

Cantaloupe shareholders to receive $11.20 per share in cash, a 34% premium to unaffected stock price
Transaction to accelerate growth in unattended retail and enhance product offering for customers in fast-growing markets and verticals
Cantaloupe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>) ("Cantaloupe"), a global technology leader offering end-to-end technology solutions for self-service commerce, today announced it has entered into a definitive agreement to be acquired by 365 Retail Markets, LLC ("365"), a leading innovator in unattended retail technologies, in an all-cash transaction with an equity value of approximately $848 million. 365 is a portfolio company of Providence Equity Partners L.L.C. ("Providence"), a specialist private equity firm focused on growth-oriented investments in media, communications, education, and technology companies across North America and Europe. Upon completion of the transaction, Cantaloupe will become a privately-held company.

CTLP

Cantaloupe To Be Acquired By 365 Retail Markets In $848M All-Cash Deal At $11.20 Per Share

WIIM

Meta shares are trading higher following reports indicating the company's WhatsApp will show adds and offer paid subscriptions.

Loop Capital analyst Rob Sanderson initiates coverage on MNTN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNTN#NYSE">MNTN</a>) with a Buy rating and announces Price Target of $29.

Initiation

MNTN

Loop Capital Initiates Coverage On MNTN with Buy Rating, Announces Price Target of $29

AMAT

Applied Materials And CEA-Leti Announce Next Phase Of Collaboration To Accelerate Innovation In Specialty Semiconductors

Rep. Marjorie Taylor Greene (R-Ga.) expressed her disapproval of U.S. involvement in foreign wars, particularly the ongoing <a href="https://www.benzinga.com/markets/equities/25/06/45944854/irans-missile-stockpile-may-be-shrinking-as-strikes-on-israel-taper-off-says-think-tank-lmt-rtx-gd-in-focus">Israel-Iran conflict</a>.
What Happened:&nbsp;Greene, via a post on X on Sunday, criticized those who are supporting U.S. involvement in the Israel-Iran war. She stated that this conflict is exposing the true supporters of the America First/MAGA movement and those who are merely pretending.
She also expressed her disapproval of those who are advocating&nbsp;for the U.S. to become&nbsp;fully involved in the war, calling it &#8220;disgusting&#8221; to wish for the murder of innocent people. Greene emphasized that the real America First/MAGA supporters are against foreign wars and want world peace.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Everyone is finding out who are real America First/MAGA and who were fake and just said it bc it was popular. Unfortunately the list of fakes are becoming quite long and exposed themselves quickly. Anyone slobbering for the U.S. to become fully involved in the Israel/Iran war…
&mdash; Rep. Marjorie Taylor Greene&#x1f1fa;&#x1f1f8; (@RepMTG) <a href="https://twitter.com/RepMTG/status/1934375883332046933?ref_src=twsrc%5Etfw">June 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
She warned that the conflict could quickly engulf the Middle East and NATO, forcing countries to take sides. Greene stressed that the America First/MAGA movement advocates for world peace and the protection of U.S. military personnel.
SEE ALSO:&nbsp;<a href="https://benzinga.com/trading-ideas/movers/25/06/45940856/oklo-quantum-computing-and-transocean-are-among-top-10-mid-cap-gainers-last-week-june-9-13-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?</a>
Why It Matters: Greene&#8217;s stance reflects a growing sentiment among some Americans <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45944853/rate-cut-odds-50-50-amid-israel-iran-conflict-says-jerome-powells-ex-advisor-jon-faust">who are tired of the U.S.&#8217;s </a>involvement in foreign conflicts. This comes as President Trump disclosed his knowledge of Israel&#8217;s planned attacks on Iran, stating that he tried to delay them in hopes of securing a deal. Trump clarified that the U.S. had no involvement in Israel&#8217;s recent attack on Iran but expressed readiness to respond if attacked.
Meanwhile, economists predict that the Israel-Iran airstrikes will have a &#8216;pretty limited&#8217; <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45943707/us-economy-to-face-pretty-limited-impact-from-israel-iran-airstrikes-with-only-a-tiny-bit-recession-risk-say-economists">impact on the U.S. economy, </a>with only a &#8216;tiny bit&#8217; recession risk. However, Greene&#8217;s tweet highlights the human and financial costs of war, noting the trillions spent in the Middle East and the impact on U.S. military personnel.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/politics/25/06/45942949/white-house-orders-scrutiny-of-spacex-contracts-even-as-trump-musk-relationship-warms-report" target="_blank" rel="noreferrer noopener">White House Orders Scrutiny Of SpaceX Contracts Even As Trump-Musk Relationship Warms: Report</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Politics

Marjorie Taylor Greene Slams 'Fake' America First Supporters Over Israel-Iran Conflict: 'We Do Not Want To Be Involved Or Required To Pay For Any Of It'

U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 700 points during the session following Israel&#8217;s surprise airstrike on Iranian nuclear sites.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Leo Mariani
<ul class="wp-block-list">
<li>Analyst Firm: Roth Capital</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Initiated coverage on Prairie Operating Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROP#NASDAQ">PROP</a>) with a Buy rating and a price target of $8 on June 12. This analyst sees around 104% upside in the stock.</li>
<li>Recent News: On June 9, Prairie Operating reaffirmed $1 billion, multi-year reserve-based lending credit facility with Citibank.</li>
</ul>
Analyst: Josh Sullivan
<ul class="wp-block-list">
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Maintained a Buy rating on TAT Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) and raised the price target from $35 to $36 on June 11. This analyst sees around 30% surge in the stock.</li>
<li>Recent News: On May 29, TAT Technologies announced the pricing of public offering of ordinary shares and secondary offering by selling shareholders.</li>
</ul>
Analyst: Andres Sheppard 
<ul class="wp-block-list">
<li>Analyst Firm: Cantor Fitzgerald</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Downgraded rating on Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) from Overweight to Neutral with a price target of $9 on June 12. This analyst sees around 2% upside in the stock.</li>
<li>Recent News: On June 3, Joby Aviation announced a new agreement to explore distribution and service partnerships in Saudi Arabia with Abdul Latif Jameel.</li>
</ul>
Analyst: Jay McCanless
<ul class="wp-block-list">
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Reiterated a Neutral rating on Hovnanian Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOV#NYSE">HOV</a>) with a price target of $120 on June 11. This analyst sees around 29% upside in the stock.</li>
<li>Recent News: On May 20, Hovnanian Enterprises reported worse-than-expected second-quarter financial results.</li>
</ul>
Analyst: Doug Anmuth
<ul class="wp-block-list">
<li>Analyst Firm: JP Morgan</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained an Overweight rating on Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) and boosted the price target from $36 to $47 on June 12. This analyst sees around 12% upside in the stock.</li>
<li>Recent News: On June 11, Chewy reported a first-quarter 2025 adjusted earnings of 35 cents per share, up 12.9% year-over-year, beating the consensus of $34 cents and the management guidance of 30-35 cents.</li>
</ul>
Read More:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45946608/top-3-materials-stocks-that-could-blast-off-this-month-3">Top 3 Materials Stocks That Could Blast Off This Month</a></li>
</ul>
Photo via Shutterstock

CHWY

JOBY

PROP

TATT

5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week

STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT&#x2122;) using Penumbra's Lightning Flash&#x2122; with anticoagulation versus anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism
ALAMEDA, Calif., June 16, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4449339-1&amp;h=4010568651&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc">Penumbra, Inc</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE&nbsp;clinical trial. The pivotal, prospective, multi-center randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra's Lightning Flash&#x2122; plus anticoagulation, versus anticoagulation alone, for the treatment of acute intermediate-high risk pulmonary embolism (PE).

Penumbra Completes Enrollment In STORM-PE Clinical Trial For Treatment Of Acute Intermediate-High Risk Pulmonary Embolism

<a href="https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time?srnd=phx-technology" title="https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time?srnd=phx-technology">https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time?srnd=phx-technology</a>

Meta Shares Move Higher, Seeing Reports Indicating Co. Introduces Channel Subscriptions, Promoted Channels And Ads In Status In WhatsApp Updates Tab

Barclays analyst Lauren Lieberman maintains Primo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRMB#NYSE">PRMB</a>) with a Overweight and lowers the price target from $40 to $38.

PRMB

Barclays Maintains Overweight on Primo Brands, Lowers Price Target to $38

<a href="https://pr.report/bjew">WidePoint Corporation</a><a href="https://pr.report/bjex">(NYSE:</a><a href="https://www.benzinga.com/stock/WYY#NYSE">WYY</a>), the federally certified provider of Trusted Mobility Management (TM2) solutions, announced today that it has secured a three-year deal valued at $1.06 million to deliver External Certification Authority (ECA) Token Certificate credentials to a top-tier, U.S.-based aerospace and defense contractor. This transaction underscores WidePoint's ongoing commitment to supporting the secure identity management needs of mission-critical national security partners.

WidePoint Secures 3-Yr Deal Valued At $1.06M To Deliver External Certification Authority Token Certificate Credentials To U.S.-Based Aerospace And Defense Contractor

Robin Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 965,000 common shares at an offering price of $5.25, for gross proceeds of approximately $5.1 million (the "Offering"), before deducting commissions and offering expenses, in a registered direct offering priced at-the-market under Nasdaq rules.
Maxim Group LLC is acting as the sole placement agent for the Offering.

Offerings

RBNE

Robin Energy Announces $5.1M At-the-Market Registered Direct Offering Of 965,000 Shares At $5.25 Per Share

Press Releases

SAVA DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 10 Deadline in Securities Class Action – SAVA

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Legal

Cassava Sciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SAVA

SAVA Deadline Today: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit

Cassava Sciences Licenses Simufilam Method of Treatment Patent

Earnings

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Health Care

General

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Management

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Comments

Cassava Sciences

Noticias

Últimas noticias sobre Cassava Sciences (NASDAQ:SAVA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL